SJN
Sung Ji Nam Scotiabank Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
36%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
71.4%
Neutral
28.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Sector Outperform
Maintained
| $60 |
34%
downside
| 2 | +49% |
0
%
| 31 Jul ‘25 7 months ago |
|
|
|
Sector Outperform
Maintained
| $75 |
37%
upside
| 1 | +0.85% |
0
%
| 11 Jul ‘25 8 months ago |
|
|
|
Sector Outperform
Upgraded
| $275 |
38%
upside
| 1 | -3.3% |
0
%
| 11 Jul ‘25 8 months ago |
|
|
|
Sector Outperform
Upgraded
| $590 |
16%
upside
| 2 | +18% |
0
%
| 11 Jul ‘25 8 months ago |
|
|
|
Sector Perform
Downgraded
| $125 |
1%
upside
| 1 | – |
–
| 11 Jul ‘25 8 months ago |
|
|
|
Sector Outperform
Maintained
| $40 |
48%
upside
| 1 | +64% |
0
%
| 21 May ‘25 9 months ago |
|
|
|
Sector Outperform
Maintained
| $40 |
106%
upside
| 1 | +258% |
0
%
| 21 May ‘25 9 months ago |
|
|
|
Sector Perform
Downgraded
| $6 |
25%
upside
| 2 | -50% |
0
%
| 21 May ‘25 9 months ago |
|
|
|
Sector Perform
Maintained
| $4 |
257%
upside
| 1 | – |
–
| 2 Apr ‘25 11 months ago |
|
|
|
Sector Outperform
Maintained
| $18 |
253%
upside
| 1 | -29% |
0
%
| 25 Mar ‘25 11 months ago |
|
|
|
Sector Outperform
Maintained
| $2 |
44%
upside
| 1 | +4.5% |
0
%
| 25 Mar ‘25 11 months ago |
|